Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace.
Why purchase an Insight Pharma Report?
Current information on highly relevant topics including biomarkers, pharmacogenomics, molecular diagnostics, predictive toxicology, inflammatory disease therapeutics, metabolic disease therapeutics, and R&D productivity.
Evaluation of the leading trends and breakthroughs within each field, as well as promising early-stage developments.
Analysis of the probability of success for various applications of each technology, and their wider business implications.
Expert insight based on interviews with key personnel in companies at the forefront of technological advances. These experts share their views on their technology's current status, applications in drug development or diagnostics, future direction, and the general market environment.
Competitive insight into the business strategies and activities of key companies.